Morteza Marandi
Psychiatry · Cerritos, CANPI 1366587594
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,867 of the $7,213 with a category attached, or 67.5%. 13 manufacturers reported payments, led by Neurocrine Biosciences, Inc. at 37.4% of the total. Reporting peaked in 2023 at $2,739 and has fallen 96.4% since, to $99 in 2025. Among psychiatry clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 83 payments — averaging $86.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$3K
- Johnson & Johnson$1K
- Sunovion Pharmaceuticals Inc.$841
- Teva Pharmaceuticals USA, Inc.$443
- Sage Therapeutics, LLC$416
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$341
- plus $1K from 7 others
Across 679 payments — averaging $9379.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$1.2M
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$954K
- E.r. Squibb & Sons, L.L.C.$838K
- Sanofi Pasteur Inc.$735K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$639K
- Sage Therapeutics, LLC$522K
- plus $1.5M from 8 others
What the payments were for
- Consulting fees$4166%
- Travel & lodging$1,93027%
- Food & beverage$4,86767%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 15 | $2,698 |
| Johnson & Johnson | 43 | $1,455 |
| Sunovion Pharmaceuticals Inc. | 7 | $841 |
| Teva Pharmaceuticals USA, Inc. | 4 | $443 |
| Sage Therapeutics, LLC | 1 | $416 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $341 |
| Otsuka America Pharmaceutical, Inc. | 2 | $242 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $175 |
| AbbVie | 1 | $128 |
| Bioxcel Therapeutics, Inc. | 1 | $125 |
| Acadia Pharmaceuticals Inc | 1 | $125 |
| Alkermes, Inc. | 1 | $125 |
| Indivior Inc. | 1 | $100 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LATUDA$841
- ARISTADA$500
- ABILIFY MAINTENA$242
- AUSTEDO$228
- INVEGA SUSTENNA$228
- INVEGA TRINZA$228
- SPRAVATO$224
- VRAYLAR$128
- IGALMI$125
- UZEDY$125
- NUPLAZID$125
- ARISTADA INITIO$125
- CAPLYTA$125
- INGREZZA$106
How this compares
$7,213 in reported general payments places this provider in the 90th percentile of 4,954 psychiatry providers in California.
Other psychiatry in Cerritos
- Gustavo AlvaOrange$5.8M
- John KooSan Francisco$3M
- Jason KelloggIrvine$2.7M
- Jonathan MeyerSan Diego$2.3M
- Charles Tuan-Tu NguyenIrvine$2.1M
- Manoj WaikarLos Gatos$1.9M
- Gerald MaguireSan Juan Capistraco$1.8M
- Salima BrillmanSunnyvale$1.4M
- Bibi DasStanford$1.4M
- Konstantinos TripodisBurbank$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.